Power morcellators: A review of current practice and assessment of risk

Sangeeta Senapati, Frank F. Tu, Javier F. Magrina

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


Power morcellation has come under scrutiny because of a highly publicized case of disseminated leiomyosarcoma following a laparoscopic hysterectomy. A recent Federal and Drug Administration safety communication discouraging use of power morcellators on presumed uterine leiomyoma further highlights the need for reexamination of uterine tissue extraction. This clinical opinion aims to summarize current approaches to uterine/fibroid tissue extraction including the associated immediate and long-term potential risks of open power morcellation. The known data about risk of uterine sarcoma is reviewed followed by a discussion of acceptable risk and informed consent in the context of shared-decision making.

Original languageEnglish (US)
Pages (from-to)18-23
Number of pages6
JournalAmerican journal of obstetrics and gynecology
Issue number1
StatePublished - Jan 1 2015


  • hysterectomy
  • leiomyoma
  • morcellation
  • myomectomy
  • uterine malignancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Power morcellators: A review of current practice and assessment of risk'. Together they form a unique fingerprint.

Cite this